I posted something similar a while back suggesting they take a leaf out of CUV's (Clinuvel Pharma's) book by holding road shows with HNW and UHNW individuals and family offices, and offer them private placements at a premium to current share price.
I believe it would add a lot of confidence and help diversify the share register rather than consolidate power in a few funds. Also could be a lot cheaper than engaging a broker/ IB to help with a raise.
Ann: Results Demonstrating Restoration of Normal Pre-Disease Flow, page-14
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$9.99 |
Change
-0.910(8.35%) |
Mkt cap ! $211.1M | |||
| Open | High | Low | Value | Volume |
| $10.50 | $10.79 | $9.30 | $1.477M | 149.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2000 | $9.70 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $9.99 | 1999 | 1 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| AVR (ASX) Chart |